Markus Haeberlein
Chief Tech/Sci/R&D Officer at ALKERMES PLC
Markus Haeberlein active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | - | - |
Career history of Markus Haeberlein
Former positions of Markus Haeberlein
| Companies | Position | Start | End |
|---|---|---|---|
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - | |
| PROTEOSTASIS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2012 | - |
Training of Markus Haeberlein
| Royal Institute of Technology | Doctorate Degree |
Statistics
International
| United States | 3 |
| Sweden | 2 |
| Ireland | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ALKERMES PLC | Health Technology |
| Private companies | 2 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
- Stock Market
- Insiders
- Markus Haeberlein
- Experience
